Juno Lighting LLC (NASDAQ:JUNO)’s share price traded up 6.4% during trading on Monday . The company traded as high as $33.48 and last traded at $33.48, with a volume of 1,441,813 shares traded. The stock had previously closed at $31.46.

A number of equities analysts have commented on the stock. FBR & Co set a $61.00 price objective on shares of Juno Lighting and gave the stock a “buy” rating in a research report on Friday, August 5th. Maxim Group cut their price target on shares of Juno Lighting from $80.00 to $50.00 and set a “buy” rating for the company in a report on Friday, August 5th. Leerink Swann reiterated a “buy” rating and issued a $86.00 price target on shares of Juno Lighting in a report on Thursday, July 14th. Zacks Investment Research downgraded shares of Juno Lighting from a “hold” rating to a “sell” rating in a report on Tuesday, July 12th. Finally, Cowen and Company reiterated a “buy” rating and issued a $55.00 price target on shares of Juno Lighting in a report on Sunday, July 10th. One analyst has rated the stock with a sell rating, three have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Juno Lighting currently has an average rating of “Buy” and a consensus target price of $52.05.

The stock’s market cap is $3.36 billion. The stock has a 50 day moving average of $33.46 and a 200-day moving average of $37.14.

Juno Lighting (NASDAQ:JUNO) last announced its quarterly earnings results on Thursday, August 4th. The biopharmaceutical company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by $0.23. The firm had revenue of $27.60 million for the quarter, compared to the consensus estimate of $14.26 million. During the same period last year, the business posted ($0.35) earnings per share. The business’s revenue for the quarter was up 121.5% on a year-over-year basis. Equities analysts predict that Juno Lighting LLC will post ($2.29) earnings per share for the current fiscal year.

In other news, Director Richard Klausner sold 12,000 shares of the business’s stock in a transaction on Wednesday, May 18th. The shares were sold at an average price of $40.00, for a total transaction of $480,000.00. Following the completion of the transaction, the director now owns 858,799 shares of the company’s stock, valued at $34,351,960. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, General Counsel Bernard J. Cassidy sold 3,116 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $39.03, for a total transaction of $121,617.48. Following the transaction, the general counsel now directly owns 55,511 shares of the company’s stock, valued at approximately $2,166,594.33. The disclosure for this sale can be found here.

Several large investors recently modified their holdings of JUNO. BNP Paribas Arbitrage SA boosted its stake in shares of Juno Lighting by 27.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 51,206 shares of the biopharmaceutical company’s stock worth $2,252,000 after buying an additional 10,884 shares in the last quarter. Swiss National Bank bought a new stake in shares of Juno Lighting during the fourth quarter worth $2,603,000. RS Investment Management Co. LLC boosted its stake in shares of Juno Lighting by 11.4% in the fourth quarter. RS Investment Management Co. LLC now owns 64,217 shares of the biopharmaceutical company’s stock worth $2,824,000 after buying an additional 6,557 shares in the last quarter. US Bancorp DE boosted its stake in shares of Juno Lighting by 1.8% in the fourth quarter. US Bancorp DE now owns 88,700 shares of the biopharmaceutical company’s stock worth $3,900,000 after buying an additional 1,600 shares in the last quarter. Finally, California Public Employees Retirement System boosted its stake in shares of Juno Lighting by 878.7% in the fourth quarter. California Public Employees Retirement System now owns 105,700 shares of the biopharmaceutical company’s stock worth $4,648,000 after buying an additional 94,900 shares in the last quarter.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.